PEDRO PABLO
ESPAÑA YANDIOLA
Investigador hasta 2024
Hospital Universitario Araba
Vitoria, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Araba (9)
2023
-
Leukocyte differential and cell population data in the evaluation of SARS-CoV-2 and other infections
Journal of Laboratory and Precision Medicine, Vol. 8
2022
-
Diagnostic potential of leukocyte differential and cell population data in prediction of COVID-19 among related viral and bacterial infections at Emergency Department
Clinical Chemistry and Laboratory Medicine
2021
-
Leukocyte differential and reactive lymphocyte counts from Sysmex XN analyzer in the evaluation of SARS-CoV-2 infection
Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 81, Núm. 5, pp. 394-400
2016
-
Duration of antibiotic treatment in community-acquired pneumonia: A multicenter randomized clinical trial
JAMA Internal Medicine, Vol. 176, Núm. 9, pp. 1257-1265
-
High Body Mass Index as a Risk Factor for Hospitalization Due to Influenza: A Case-Control Study
Archivos de Bronconeumologia, Vol. 52, Núm. 6, pp. 299-307
2014
-
Predictive factors of severe multilobar pneumonia and shock in patients with influenza
Emergency Medicine Journal, Vol. 31, Núm. 4, pp. 301-307
2013
-
Risk factors and effectiveness of preventive measures against influenza in the community
Influenza and other Respiratory Viruses, Vol. 7, Núm. 2, pp. 177-183
2012
-
Effectiveness of hand hygiene and provision of information in preventing influenza cases requiring hospitalization
Preventive Medicine, Vol. 54, Núm. 6, pp. 434-439
-
Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: Influence of neuraminidase inhibitors
Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 7, pp. 1739-1745